Literature DB >> 10842198

Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4.

C Landry1, F Brasseur, G C Spagnoli, E Marbaix, T Boon, P Coulie, D Godelaine.   

Abstract

Monoclonal antibody (Mab) 57B, which was raised against a recombinant MAGE-A3 protein, was tested for its ability to stain cells expressing various members of the MAGE-A gene family. COS-7 cells transfected with cDNAs encoding MAGE-A1, A2, A3, A4, A6, or A12 were stained, whereas those transfected with MAGE-A8, A9, A10, or A11 cDNAs were not. However, in tissue sections, we observed a different pattern of staining: the antibody effectively stained the tumors that expressed MAGE-A4 and only these tumors, regardless of the expression of the other MAGE-A genes. It seems, therefore, that at the level of MAGE gene expression found in tumors, a level clearly lower than that observed in transfected COS cells, only the MAGE-A4 protein can be reliably detected. We conclude that the 57B Mab should be useful for tumor diagnosis related to therapeutic vaccination involving MAGE-A4. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842198     DOI: 10.1002/(sici)1097-0215(20000615)86:6<835::aid-ijc12>3.0.co;2-n

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Expression of cancer-testis (CT) antigens in placenta.

Authors:  Achim A Jungbluth; Wilson A Silva; Kristin Iversen; Denise Frosina; Bushra Zaidi; Keren Coplan; Susannah K Eastlake-Wade; Sandra B Castelli; Giulio C Spagnoli; Lloyd J Old; Martin Vogel
Journal:  Cancer Immun       Date:  2007-08-24

2.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Authors:  Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine Ambrosone; James Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

3.  Cancer/testis (CT) antigens are expressed in fetal ovary.

Authors:  Peter T Nelson; Paul J Zhang; Giulio C Spagnoli; John E Tomaszewski; Theresa L Pasha; Denise Frosina; Otavia L Caballero; Andrew J G Simpson; Lloyd J Old; Achim A Jungbluth
Journal:  Cancer Immun       Date:  2007-01-12

4.  Production of an antigenic peptide by insulin-degrading enzyme.

Authors:  Nicolas Parmentier; Vincent Stroobant; Didier Colau; Philippe de Diesbach; Sandra Morel; Jacques Chapiro; Peter van Endert; Benoît J Van den Eynde
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

5.  The biology of cancer testis antigens: putative function, regulation and therapeutic potential.

Authors:  Elisabetta Fratta; Sandra Coral; Alessia Covre; Giulia Parisi; Francesca Colizzi; Riccardo Danielli; Hugues Jean Marie Nicolay; Luca Sigalotti; Michele Maio
Journal:  Mol Oncol       Date:  2011-02-18       Impact factor: 6.603

6.  Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.

Authors:  Martin Bolli; Thomas Kocher; Michel Adamina; Ulrich Guller; Peter Dalquen; Philippe Haas; Martina Mirlacher; Franco Gambazzi; Felix Harder; Michael Heberer; Guido Sauter; Giulio C Spagnoli
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

7.  Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?

Authors:  Sylvia Adams; Luba Greeder; Elsa Reich; Yongzhao Shao; Denise Fosina; Nicole Hanson; Jodie Tassello; Baljit Singh; Giulio C Spagnoli; Sandra Demaria; Achim A Jungbluth
Journal:  Cancer Immunol Immunother       Date:  2011-04-05       Impact factor: 6.968

8.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

9.  Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Authors:  Daniela Bandić; Antonio Juretić; Bozena Sarcević; Viktor Separović; Mirjana Kujundzić-Tiljak; Tvrtko Hudolin; Giulio C Spagnoli; Dinko Cović; Mirko Samija
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

10.  Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.

Authors:  Teresa Cabezón; Irina Gromova; Pavel Gromov; Reza Serizawa; Vera Timmermans Wielenga; Niels Kroman; Julio E Celis; José M A Moreira
Journal:  Mol Cell Proteomics       Date:  2012-11-20       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.